$Longeveron (LGVN.US)$ The Alzheimer's disease market is exp...

The Alzheimer's disease market is expected to grow in the coming years due to a number of factors, including increased awareness, advancements in drug development, and rising prevalence of the disease:

Market size
The global Alzheimer's therapeutics market was valued at $4.82 billion in 2023 and is expected to reach $8.18 billion by 2032. The global Alzheimer's drugs market was valued at $7.7 billion in 2023 and is expected to reach $12.4 billion by 2032.

Market drivers
The main drivers of the Alzheimer's disease market include:

Aging population: The global population is aging, which is leading to an increase in the number of Alzheimer's cases.

Drug development: There are many advancements in drug development, including the launch of new therapies and the entry of disease-modifying therapies into the market.

Funding: There is increasing public and private funding for research into neurodegenerative diseases.

Market segments
The cholinesterase inhibitors segment captured the largest share of the global Alzheimer's drugs market in 2022. The combination drugs segment is expected to grow the fastest in the coming years.